Skip to main content
Veterinary Medicines

Nobivac Respira Bb vet. suspension for injection in pre-filled syringe for dogs

Authorised
  • Bordetella bronchiseptica, celms Bb7 92932, fimbrija

Auðkenning lyfsins

Heiti lyfs:
Nobivac Respira Bb vet. suspension for injection in pre-filled syringe for dogs
Nobivac Respira Bb suspensija injekcijām pilnšļircē suņiem
Virkt efni:
Dýrategundir:
  • Hundur
Íkomuleið:
  • Til notkunar undir húð

Upplýsingar um lyfið

Virkt efni / Styrkur:
  • Aðeins í boði í English
    88.00
    enzyme-linked immunosorbent assay unit
    /
    1.00
    millilitre(s)
Lyfjaform:
Withdrawal period by route of administration:
  • Subcutaneous use
    • Hundur
ATC flokkun (dýralyf):
  • QI06AE02
Staða markaðsleyfis:
  • Gilt
Authorised in:
  • Lettland
Áletrun:
  • Aðeins í boði í dansk
  • Aðeins í boði í dansk

Viðbótarupplýsingar

Entitlement type:
  • Markaðsleyfi
Markaðsleyfishafi:
  • Intervet International B.V.
Markaðsleyfi gefið út:
Framleiðandi sem ber ábyrgð á lokasamþykkt:
  • INTERVET INTERNATIONAL B.V.
Útgáfuland markaðsleyfis:
  • Lettland
Ábyrgt yfirvald:
  • Food And Veterinary Service
Markaðsleyfisnúmer:
  • V/DCP/20/0055
Dagsetning leyfisbreytingar:
Umsjónarland (RMS):
  • Danmörk
Númer verkferlis:
  • DK/V/0123/001
Þátttökulönd (CMS):
  • Austurríki
  • Belgía
  • Búlgaría
  • Króatía
  • Kýpur
  • Tékkland
  • Eistland
  • Finnland
  • Frakkland
  • Þýskaland
  • Grikkland
  • Ungverjaland
  • Ísland
  • Írland
  • Ítalía
  • Lettland
  • Litáen
  • Lúxemborg
  • Holland
  • Noregur
  • Pólland
  • Portúgal
  • Rúmenía
  • Slóvakía
  • Slóvenía
  • Spánn
  • Svíþjóð
  • Bretland (Norður-Írland)

Skjöl

Combined File of all Documents

Published:
Latvian (PDF)
Download

Other Product Information

Published:
English (PDF)
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."